The Emerging Utility of Co-Crystals in Drug Discovery and Development
- 1 January 2008
- book chapter
- Published by Elsevier
- p. 373-404
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- The Co‐Crystal Approach to Improve the Exposure of a Water‐Insoluble Compound: AMG 517 Sorbic Acid Co‐Crystal Characterization and PharmacokineticsJournal of Pharmaceutical Sciences, 2008
- Polymorphism in Carbamazepine CocrystalsCrystal Growth & Design, 2008
- Poorly Soluble Marketed Drugs Display Solvation Limited SolubilityJournal of Medicinal Chemistry, 2007
- Performance comparison of a co-crystal of carbamazepine with marketed productEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution ratesAdvanced Drug Delivery Reviews, 2007
- The Salt−Cocrystal Continuum: The Influence of Crystal Structure on Ionization StateMolecular Pharmaceutics, 2007
- Pharmaceutical Co-CrystalsJournal of Pharmaceutical Sciences, 2006
- Evaluation of Kilogram-Scale Sonagashira, Suzuki, and Heck Coupling Routes to Oncology Candidate CP-724,714Organic Process Research & Development, 2005
- Resolution of optical isomers of 4-amino-p-chlorobutyric acid lactam by co-crystallizationJournal of Chemical Crystallography, 1996
- Optical resolution of phosphinates and phosphine oxides by complex formation with optically active 2,2'-dihydroxy-1,1'-binaphthyl and crystallographic study of two diastereomeric complexes with methyl methylphenylphosphinateThe Journal of Organic Chemistry, 1988